Clinical Trials List
2021-11-01 - 2025-05-31
Phase II
Recruiting2
ICD-10C18.9
Malignant neoplasm of colon, unspecified
ICD-10C7A.029
Malignant carcinoid tumor of the large intestine, unspecified portion
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.9
Malignant neoplasm of colon, unspecified
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chiun Hsu 無
- 張端瑩 無
- 陳國興 無
- Chih-Hung Hsu 無
- TA-CHEN HUANG 無
- JHE-CYUAN GUO 無
- 林宗哲 無
- YU-YUN SHAO 無
- 梁逸歆 無
- Ann-Lii Cheng 無
- Ying-Chun Shen 無
- 呂理駿 無
- 林昭文 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃盈慈 無
- Peng-Chan Lin 無
- Po-Wen Lin 無
- Jui-Hung Tsai 無
- 陳柏全 無
- Shang-Hung Chen 無
- 詹仁豪 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
204 participants
